These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study. Lin MS; Dai YS; Pwu RF; Chen YH; Chang NC Intern Med J; 2005 Mar; 35(3):188-90. PubMed ID: 15737140 [TBL] [Abstract][Full Text] [Related]
7. [Toxic epidermal necrolysis in adults]. David M; Grunwald MH; Sandbank M; Feuerman EJ Harefuah; 1981 Jan; 100(2):61-4. PubMed ID: 7262655 [No Abstract] [Full Text] [Related]
8. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis. Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164 [TBL] [Abstract][Full Text] [Related]
9. [Toxic epidermal necrolysis in children]. Herrmann WA Ned Tijdschr Geneeskd; 1970 Oct; 114(43):1793-6. PubMed ID: 5528544 [No Abstract] [Full Text] [Related]
10. [Stevens-Johnson syndrome and toxic epidermal necrolysis; therapy policy in these life-threatening illnesses. Netherlands Work Group Toxic Epidermal Necrolysis]. van der Meer JB Ned Tijdschr Geneeskd; 1996 Jul; 140(30):1538-43. PubMed ID: 8765761 [No Abstract] [Full Text] [Related]
11. [Drug damage in children]. Harnack K Z Haut Geschlechtskr; 1967 Dec; 42(23):883-90. PubMed ID: 5595856 [No Abstract] [Full Text] [Related]